These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 12106524)
1. [Adherence to antiretroviral drug therapy. A systematic review]. Puigventós F; Riera M; Delibes C; Peñaranda M; de la Fuente L; Boronat A Med Clin (Barc); 2002 Jun; 119(4):130-7. PubMed ID: 12106524 [TBL] [Abstract][Full Text] [Related]
2. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK; Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573 [TBL] [Abstract][Full Text] [Related]
3. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK; MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060 [TBL] [Abstract][Full Text] [Related]
4. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. Walsh JC; Mandalia S; Gazzard BG AIDS; 2002 Jan; 16(2):269-77. PubMed ID: 11807312 [TBL] [Abstract][Full Text] [Related]
5. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)]. Panel de expertos de GESIDA y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714 [TBL] [Abstract][Full Text] [Related]
6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
7. Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients - a systematic review. Mathes T; Pieper D; Antoine SL; Eikermann M HIV Med; 2013 Nov; 14(10):583-95. PubMed ID: 23773654 [TBL] [Abstract][Full Text] [Related]
8. A prospective study of predictors of adherence to combination antiretroviral medication. Golin CE; Liu H; Hays RD; Miller LG; Beck CK; Ickovics J; Kaplan AH; Wenger NS J Gen Intern Med; 2002 Oct; 17(10):756-65. PubMed ID: 12390551 [TBL] [Abstract][Full Text] [Related]
9. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E; Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227 [TBL] [Abstract][Full Text] [Related]
10. Predictors of short-term success of antiretroviral therapy in HIV infection. Oette M; Kroidl A; Göbels K; Stabbert A; Menge M; Sagir A; Kuschak D; O'hanley T; Bode JG; Häussinger D J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458 [TBL] [Abstract][Full Text] [Related]
11. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa. Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454 [TBL] [Abstract][Full Text] [Related]
12. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. Gordillo V; del Amo J; Soriano V; González-Lahoz J AIDS; 1999 Sep; 13(13):1763-9. PubMed ID: 10509579 [TBL] [Abstract][Full Text] [Related]
13. Adherence to antiretroviral treatment in patients with HIV in the UK: a study of complexity. Sherr L; Lampe F; Norwood S; Leake Date H; Harding R; Johnson M; Edwards S; Fisher M; Arthur G; Zetler S; Anderson J AIDS Care; 2008 Apr; 20(4):442-8. PubMed ID: 18449821 [TBL] [Abstract][Full Text] [Related]
14. Effects of Counselling on Adherence to Antiretroviral Treatment Among People with HIV in Estonia: A Randomized Controlled Trial. Uusküla A; Laisaar KT; Raag M; Lemsalu L; Lõhmus L; Rüütel K; Amico KR; AIDS Behav; 2018 Jan; 22(1):224-233. PubMed ID: 28717981 [TBL] [Abstract][Full Text] [Related]
15. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764 [TBL] [Abstract][Full Text] [Related]
16. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. Howard AA; Arnsten JH; Lo Y; Vlahov D; Rich JD; Schuman P; Stone VE; Smith DK; Schoenbaum EE; AIDS; 2002 Nov; 16(16):2175-82. PubMed ID: 12409739 [TBL] [Abstract][Full Text] [Related]
17. The mean levels of adherence and factors contributing to non-adherence in patients on highly active antiretroviral therapy. Williams M; Clarke T; Williams P; Barton EN West Indian Med J; 2007 Jun; 56(3):270-4. PubMed ID: 18072411 [TBL] [Abstract][Full Text] [Related]
18. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Gibb DM; Goodall RL; Giacomet V; McGee L; Compagnucci A; Lyall H; Pediatr Infect Dis J; 2003 Jan; 22(1):56-62. PubMed ID: 12544410 [TBL] [Abstract][Full Text] [Related]
19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
20. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Haddad M; Inch C; Glazier RH; Wilkins AL; Urbshott G; Bayoumi A; Rourke S Cochrane Database Syst Rev; 2000; (3):CD001442. PubMed ID: 10908497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]